Stability of synthetic exendin-4 in human plasma In vitro

Protein and Peptide Letters

Volumn 14, Issue 1, 2007, Pages 19-25

  Chen, Jie ^a   Yu, Ling ^a   Wang, Liping ^a   Fang, Xuexun ^a   Li, Li ^b   Li, Wei ^a,c  

^a JILIN UNIVERSITY   (China)

^b Changchun Institute of Biological Products   (China)

^c NONE   (China)

Author keywords

Dipeptidyl peptidase IV(DPP IV); Glucagon like peptide; Stability; Synthetic exendin 4

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; PEPTIDE; VENOM;

AMINO ACID SEQUENCE; ARTICLE; BLOOD; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MOLECULAR GENETICS; PROTEIN SECONDARY STRUCTURE;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; VENOMS;

EID: 33845989145     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986607779117272     Document Type: Article

References (27)

1. Nielsen, L.L., Young, A.A., Parkes, G.D. (2004) Regulatory Peptides, 117, 77-88.
2. Kharroubi, I., Ladrière, L., Cardozo, A.K., Dogsan, Z., Cnop, M., Eizirik, D.L. (2004) Endocrinology, 45, 5087-5096.
3. Egan, J.M., Clocquet, A.R., Elahi, D. (2002) J. Clin. Endocrinol. Metab., 87, 1282-1290.
4. Kolterman, O.G., Buse, J.B., Fineman, M.S., Gaines, E., Heintz, S., Bicsak, T.A., Taylor, K., Kim, D., Aisporna, M., Wang, Y., Baron, A.D. (2003) J. Clin. Endocrinol. Metab., 88, 3082-3089.
5. Parks, D., Gedulin, S., Smith, P., Young, A. (2001) Diabetes, 50, A313.
6. Jodka, C., Gedulin, B., Young, A. (1998) Diabetes, 47, 403A.
7. Szayna, M., Doyle, M.E., Betkey, J.A., Holloway, H.W., Spencer, R.G., Greig, N.H., Egan, J.M. (2000) Endocrinology, 141, 1936-1941.
8. Tourrel, C., Bailbe, D., Lacorne, M., Meile, M.J., Kergoat, M., Portha, B. (2002) Diabetes, 51, 1443-1452.
9. Degn, K.B., Brock, B., Juhl, C.B., Djurhuus, C.B., Grubert, J., Kim, D., Han, J., Taylor, K., Fineman, M., Schmitz, O. (2004) Diabetes, 53, 2397-2403.
10. Kolterman, O.G., Buse, J.B., Fineman, M.S., Gaines, E., Heintz, S., Bicsak, T.A., Taylor, K., Kim, D., Aisporna, M., Wang, Y., Baron, A.D. (2003) J. Clin. Endocrinol. Metabol. 88, 3082-3089.
11. Joy, S.V., Rodgers, P.T., Scates, A.C. (2005) Ann. Pharmacother., 39, 110-118.
12. Seebach, D., Matthews, J. L. (1997) Chem. Commun. (Cambridge), 2015.
13. Frackenpohl, J., Arvidsson, P., Schreiber, J. V. Seebach, D. (2001) Chembiochem, 2, 445-455.
14. Gademann, K., Ernst, M., Hoyer, D., Seebach, D. (1999) Angew. Chemie Internat. Ed., 38, 1223-1226.
15. Gademann, K., Ernst, M., Seebach, D., Hoyer, D. (2000) Helvet. Chim. Acta, 83, 16-33.
16. Bozu, B., Fulop, F., Toth, G.K., Toth, G., Szucs, M. (1997) Neuropeptides, 31, 367-72.
17. Xiao, Q., Jeng, W. and Wheeler, M.B. (2000) J. Mol. Endocrinol., 25, 321-335.
18. Deacon, C.F., Knudsen, L.B., Madsen, K., Wiberg, F.C., Jacobsen, O., Holst, J.J. (1998) Diabetologia, 41, 271-278.
19. Buckley, D.I., Lundquist, P. (1992) Regulatory Peptides, 40, 117.
20. Weihofen, W.A., Liu, J., Reutter, W., Saenger, W., Fan, H. (2004) J. Biolog. Chem., 279, 43330-43335.
21. Ritzel, U., Leonhardt, U., Ottleben, M., Ruhmann, A., Eckart, K., Spiess, J., Ramadori, G. (1998) J. Endocrinol., 159, 93-102.
22. Doyle, M.E., Theodorakis, M.J., Holloway, H.W., Bernier, M., Greig, N.H., Egan, J.M. (2003) Regulatory peptides, 114, 153-158.
23. López de Maturana, R., Willshaw, A., Kuntzsch, A., Rudolph, R., Donnelly, D. (2003) J. Biol. Chem., 278, 10195-10200.
24. Rafizadeh, C.M., Yang, H., Rodgers, B.D., Beday, A. (1997) J. Biol. Chem., 272, 21201-21206.
25. López de Maturana, R., Donnelly, D. (2002) FEBS Lett., 530, 244-248.
26. Neidigh, J.W., Fesinmeyer, R.M., Prickett, K.S., Andersen, N.H. (2001) Biochemistry, 40, 13188-13200.
27. Andersen, N.H., Brodsky, Y., Neidigh, J.W., Prickett, K.S. (2002) Bioorg. Med. Chem., 10, 79-85.